Search for stocks /

EPL Limited:Plastic Tubes, Global Ambitions.₹1,206 Cr Revenue. Beauty & Cosmetics on Fire.

EPL Ltd Q3 FY26 | EduInvesting
Q3 FY26 Results · 3rd Consecutive Double-Digit Growth

EPL Limited:
Plastic Tubes, Global Ambitions.
₹1,206 Cr Revenue. Beauty & Cosmetics on Fire.

They make fancy tubes. You laugh. But your toothpaste, your face cream, your girlfriend’s mascara — all living in EPL tubes. Blackstone backed. Indorama invested. Now growing like crazy. This is the unglamorous glamour stock.

Market Cap₹5,789 Cr
CMP₹181
P/E Ratio14.0x
Div Yield2.77%
ROCE18.7%

The Tube Factory That Became a Global Darling

  • 52-Week High / Low₹254 / ₹175
  • Q3 FY26 Revenue₹1,149 Cr
  • Q3 FY26 PAT₹90.9 Cr
  • Q3 FY26 EPS₹2.80
  • Annualised EPS (Q3×4)₹11.20
  • Book Value₹81.9
  • Price to Book2.21x
  • Dividend Yield2.77%
  • Debt / Equity0.32x
  • Interest Coverage5.43x
The Auditor’s Hot Take: Three quarters, three wins. Revenue +13.3% YoY. EBITDA +12%. The stock is down -15% in the last three months while the company executes like it’s possessed. Somewhere, an old-money wealth manager is quietly buying. Somewhere, a momentum trader is being confused. Meanwhile, they’re making tubes for brands you actually use. ROCE improved to 18.7%. Net leverage at 0.65x. And Indorama (a $15 billion global packaging powerhouse) just bought 24.9% of the company. This isn’t a micro-cap hidden gem anymore. It’s just a cap that the index fund algorithms haven’t fully priced in yet.

Welcome to the Unglamorous $15 Billion Acquisition

Let’s be honest: you don’t think about tubes. Your toothpaste comes in a tube. Your face cream comes in a tube. That mascara your wife swears by? Tube. That expensive German scar cream? Tube. Nobody wakes up and says, “You know what I love? Laminated plastic tubes.” And yet, here we are. EPL Limited manufactures approximately 42 billion tubes annually across 21 manufacturing facilities spread across four continents, commanding roughly 35% of the global oral care tube market and roughly 10% of the beauty & cosmetics tube market. They are, quite literally, the largest specialty packaging company in the world.

The company was acquired by Blackstone in 2019 from the Essel group for an undisclosed amount. For the past 6.5 years, Blackstone has been quietly building this business. Then, in February 2025, something unusual happened: Indorama Ventures (a Thai petrochemical and packaging behemoth with $15 billion in annual revenue) came in and purchased 24.9% of EPL from Blackstone for an undisclosed sum, reducing Blackstone’s stake to 26.4%. This is not a fund looking to exit. This is a strategic investor making a 20-year bet. And the market has essentially yawned.

Q3 FY26 delivered exactly what management promised: highest-ever quarterly revenue at ₹1,206 crore. Third straight quarter of double-digit growth. EBITDA margins holding firm at 20.1%. ROCE expanding to 18.7%. A new MD (Hemant Bakshi, a packaging industry veteran) was appointed effective January 2026. Leadership transition complete. Execution intact. And the stock trades at a P/E of 14.0x — below the Nifty 500 median.

Let’s break down what actually happened, why the market is sleeping on it, and whether you should care.

Management Concall Insight (Feb 2026): “All regions delivered nearly 20% growth in Beauty & Cosmetics. We’re materially outperforming the market and highlighting accelerating market share gains.” Translation: they’re stealing customers from everyone, and nobody is stopping them.

Making Pretty Tubes. Selling Them to Everyone’s Favourite Brands.

EPL’s business model is so simple it’s almost boring. Step 1: Import or manufacture plastic laminate sheets (think a thin, multi-layer plastic sandwich). Step 2: Feed those sheets into extrusion machines that turn them into tubes. Step 3: Print logos and designs on them. Step 4: Cap them. Step 5: Ship them to brands like Colgate, P&G, Unilever, GSK, Reckitt Benckiser, Himalaya, Emami, Patanjali, and a thousand others. Step 6: Make money hand over fist.

The genius is in the integrated operations. EPL manufactures its own laminate sheets at plants in India and China, which gives them control over quality, costs, and supply chain. This is fully backward-integrated. About 90% of their laminate formulations are patented, meaning nobody can just copy them. They also manufacture in-house caps and closures — another cost advantage nobody talks about.

Revenue is split roughly: 47% Oral Care (toothpaste tubes), 53% Beauty & Cosmetics (face cream, mascara, hair colour, pharmaceuticals, food). Geographically: AMESA (Africa, Middle East, South Asia) = 32%, Americas = 24%, Europe = 22%, East Asia Pacific = 22%. This is the definition of a globally diversified business. No single customer is over-reliant. No single region can tank the whole thing.

Annual Tube Capacity42 BnGlobal Output
Oral Care Share35%Global Market
Beauty Segment53%Portfolio Mix
Operating Plants21Across 11 Countries
Contract Visibility = Cash Flow Predictability: About 50% of EPL’s revenue comes from long-term contracts (roughly 3 years tenure) with massive multinational brands. These contracts have cost pass-through clauses, meaning when the price of plastic goes up, they pass it to the customer with a lag of 3–4 months. The other 50% is negotiated annually. This structure gives EPL genuine cash flow visibility that most companies dream about. No surprises. No drama. Just compounding.
💬 Quick thought experiment: How many tubes did you use today? Toothpaste? Face wash? Sunscreen? And not once did you check the brand of the tube itself. Yet for a brand, EPL’s tube is as important as the product inside. That’s pricing power.

Q3 FY26: The Numbers That Actually Matter

error: Content is protected !!